# Opus Genetics’ Third-Quarter Loss Widens to $46.5 Million

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/53926
Published: 2026-11-11T12:15:04.000Z
Updated: 2026-11-11T12:15:04.000Z
Section: Business

> The company recorded a $0.46 loss per share, compared with $0.25 a year earlier. Revenue fell to $1.14 million from $3.08 million.

Opus Genetics posted a $46.5 million net loss for the quarter ended Sept. 30, 2026, as its loss widened from a year earlier and revenue fell to $1.14 million.

The net loss was $46.5 million, or $0.46 per share, compared with $17.5 million, or $0.25 per share, in the same quarter of 2025.

Revenue totaled $1.14 million, down from $3.08 million in the year-earlier quarter.